Strategies used in managing conversations about prostate-specific antigen (PSA) testing among family physicians (FPs): a qualitative study

Strategies used in managing conversations about prostate-specific antigen (PSA) testing among family physicians (FPs): a qualitative study

Objectives Screening for prostate cancer in healthy asymptomatic men using the prostate-specific antigen (PSA) test is controversial due to conflicting recommendations from and a lack of strong evidence regarding the benefit of population-based screening. In Canada and internationally, there is vari...

Full description

Bibliographic Details
Main Authors:	Eric Bohm, Alexander Singer, Sarah Kirby, Roger Suss, S Michelle Driedger, Ryan Maier, Laurel Thorlacius, Jeffery W Saranchuk
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-04-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/13/4/e073415.full

Similar Items

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
by: Sävblom, C, et al.
Published: (2009)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
by: Törnblom, M, et al.
Published: (2001)

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
by: Blijenberg, BG, et al.
Published: (2003)

Uji diagnostik prostate spesific antigen (PSA) pada keganasan prostat
by: , DAHESIHDEWI, Andaru, et al.
Published: (2002)

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
by: Hyungseok Cho, et al.
Published: (2022-03-01)

Prostate Specific Antigen (PSA) testing practices in an academic healthcare organization
by: Margarita Echeverri, et al.
Published: (2022-03-01)

Prognostic significance of Prostate-Specific Antigen (PSA) rate of change in patients with advanced prostate cancer
by: A E Aghaji, et al.
Published: (2005-01-01)

Effect of urinary retention on the levels of prostate specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostatic disease
by: R Chawla, et al.
Published: (2003-01-01)

Pengaruh kateterisasi terhadap hasil penetapan prostate specific antigen (PSA) pada pasien gangguan prostat
by: Perpustakaan UGM, i-lib
Published: (2005)

Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction
by: Simona Ferraro, et al.
Published: (2021-07-01)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
by: Naseruddin Höti, et al.
Published: (2023-02-01)

Prostate-specific antigen kinetics contributes to decision making for biopsy referral: the predictive implication for PSA retest in patients with elevated PSA levels
by: Minoru Kobayashi, et al.
Published: (2023-03-01)

Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.
by: Roddam, A, et al.
Published: (2005)

Erratum: Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level (British Journal of Urology International 87 (638-642))
by: Törnblom, M, et al.
Published: (2001)

Using a Recurrent Neural Network To Inform the Use of Prostate-specific Antigen (PSA) and PSA Density for Dynamic Monitoring of the Risk of Prostate Cancer Progression on Active Surveillance
by: Nikita Sushentsev, et al.
Published: (2023-06-01)

Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo.
by: Denmeade, SR, et al.
Published: (2003)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms.
by: Végvári, A, et al.
Published: (2010)

Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research
by: Littlejohns, T, et al.
Published: (2016)

Mortality reduction and cumulative excess incidence (CEI) in the prostate-specific antigen (PSA) screening era
by: Patrick W. McLaughlin, et al.
Published: (2024-03-01)

Do the Prostate-Specific Antigen (PSA) Tests That Are Ordered in Clinical Practice Adhere to the Pertinent Guidelines?
by: Mari Carmen Bernal-Soriano, et al.
Published: (2021-06-01)

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01)

Serum total prostate-specific antigen (tPSA): correlation with diagnosis and grading of prostate cancer in core needle biopsy
by: Nina Čamdžić, et al.
Published: (2021-02-01)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
by: Daniel Simanjuntak, et al.
Published: (2016-03-01)

Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA.
by: Nurmikko, P, et al.
Published: (2000)

Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age.
by: Sävblom, C, et al.
Published: (2005)

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING
by: Burton, A, et al.
Published: (2011)

Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2
by: De Nitto Simone, et al.
Published: (2023-08-01)

Analysis of mixed prostate specific antigen and Tween-20 sessile droplets for the reduction in interfacial PSA adsorption
by: Vidisha Singh Rathaur, et al.
Published: (2023-05-01)

Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis
by: Zeng-Hong Wu, et al.
Published: (2019-10-01)

The level of Prostate specific antigen (PSA) in patients with polycystic ovarian syndrome: Systematic review and Meta-analysis
by: Marzieh Saei Ghare Naz, et al.
Published: (2020-04-01)

Software client for first-person-shooting (FPS) games
by: Zhou, Weicheng.
Published: (2009)

Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys(₁₄₅) or Lys(₁₄₆) from fPSA without internal cleavages at Lys(₁₄₅) or Lys(₁₄₆).
by: Peltola, M, et al.
Published: (2011)

Prostate cancer: estimating the benefits of PSA screening.
by: Vickers, A, et al.
Published: (2009)

The Physiological Influence of Prostate size and Prostatic Specific Antigen (PSA) on The Concentrations of some Hormones and Biochemical Compounds for Males in Salah Alden Governorate
by: Wahbi A. Salman
Published: (2017-12-01)

Is prostate specific antigen (PSA) density necessary in selecting prostate cancer patients for active surveillance and what should be the cutoff in the Asian population?
by: Chiu-Fung Tsang, et al.
Published: (2019-06-01)

Diagnostic value of free-to-total PSA proportion and PSA density in prostate cancer detection for prostate volumes >= 100 cc
by: Murat Zor, et al.
Published: (2018-12-01)

The proportional difference of prostate-specific antigen (PSA) reeactivity in seminal fluid and urine using rapid test device
by: Henky KB,, et al.
Published: (2011)

Investigation of awareness rate of prostate-specific antigen (PSA) among the general public in China and analysis of influencing factors
by: Yuqin Wang, et al.
Published: (2023-05-01)

An Ultra-Rapid Biosensory Point-of-Care (POC) Assay for Prostate-Specific Antigen (PSA) Detection in Human Serum
by: Sophie Mavrikou, et al.
Published: (2018-11-01)